Stefan W. Ryter

Harvard University, USA

0000-0001-7209-5342

Stefan W. Ryter received his Ph.D. degree, in 1994, in molecular pharmacology and toxicology from the University of Southern California, Los Angeles, Calif, USA. Dr. Ryter's overall research interest is focused on molecular mechanisms of gene regulation and function with a particular relevance to stress-inducible systems such as heme oxygenase-1. Dr. Ryter also studies molecular mechanisms of lung injury and disease, with a focus on tobacco-related lung injury and chronic obstructive pulmonary disease. His research also examines molecular adaptation to environmental stress, involving inflammatory, autophagic, and apoptotic mechanisms in pulmonary cells, and therapeutic effects of inhaled carbon monoxide. Dr. Ryter serves as a coinvestigator in several NIH funded programs including a recently funded program project on the therapeutic application of carbon monoxide in sepsis. Additionally, Dr. Ryter performs an editorial service for a number of biomedical journals. Dr. Ryter also currently serves as the Scientific Liaison and Co-Program Director for the Brigham and Women’s Hospital and Lovelace Respiratory Research Institute (BWH/LRRI) Joint Lung Research Program, Albuquerque, NM, USA. Since its inception in November, 2009, this unique partnership has sought to unite the strengths of two diverse academic establishments with a common goal: the improvement of respiratory health and amelioration of pulmonary disease through multidisciplinary collaborative research and education. As a Program Scientific Liaison and Codirector, Dr. Ryter seeks to combine the clinical, bioinformatic, and bench research resources available at BWH, with the facilities at LRRI for high throughput animal screening and inhalation toxicology.

Biography Updated on 10 January 2013

Scholarly Contributions [Data Provided by ]

download